The interactions of bisphosphonates in solution and as coatings on hydroxyapatite with osteoblasts

A. Ganguli, C. Henderson, M.H. Grant, S.T. Meikle, A.W. Lloyd, I. Goldie

    Research output: Contribution to journalArticle

    15 Citations (Scopus)

    Abstract

    Aseptic loosening is one of the major causes of failure of artificial hip joints, and it can occur for several reasons, including osteolysis of the bone tissue in response to stress shielding or cellular reactions to wear debris. Any treatment of the prosthesis which could minimize the osteolytic response of bone tissue may be able to extend the life-time of the implant. Bisphosphonates are potent inhibitors of osteoclastic bone resorption, and they bind avidly to hydroxyapatite (HA). Coating the prostheses with bisphosphonates may therefore inhibit osteolysis. We have investigated the potential for this approach by determining whether bisphosphonates interact with osteoblasts in vitro. The effects of pamidronate (P), clodronate (C), and etidronate (E) in solution and when coated onto HA were investigated. P inhibited protein and collagen syntheses potently when in solution, but not after being bound to HA. When bound to HA, both P and C increased DNA, protein and collagen syntheses of osteoblasts and may encourage the osseointegration of implants. The pharmacological effects of the bisphosphonates studied altered dramatically after binding to HA. This must be fully investigated before this approach to prolonging prostheses stability can be evaluated.
    Original languageEnglish
    Pages (from-to)923-931
    Number of pages8
    JournalJournal of Materials Science: Materials in Medicine
    Volume13
    Issue number10
    DOIs
    Publication statusPublished - 2002

    Fingerprint

    Osteoblasts
    Diphosphonates
    Durapatite
    Hydroxyapatite
    Coatings
    Prostheses and Implants
    Bone
    Osteolysis
    pamidronate
    Prosthetics
    Collagen
    Bone Density Conservation Agents
    Etidronic Acid
    Tissue
    Clodronic Acid
    Hip prostheses
    Proteins
    Osseointegration
    Bone and Bones
    Hip Joint

    Keywords

    • materials science
    • bioengineering
    • bisphosphonates
    • osteoblasts

    Cite this

    @article{fb777819a110447c998c0e716c70b61a,
    title = "The interactions of bisphosphonates in solution and as coatings on hydroxyapatite with osteoblasts",
    abstract = "Aseptic loosening is one of the major causes of failure of artificial hip joints, and it can occur for several reasons, including osteolysis of the bone tissue in response to stress shielding or cellular reactions to wear debris. Any treatment of the prosthesis which could minimize the osteolytic response of bone tissue may be able to extend the life-time of the implant. Bisphosphonates are potent inhibitors of osteoclastic bone resorption, and they bind avidly to hydroxyapatite (HA). Coating the prostheses with bisphosphonates may therefore inhibit osteolysis. We have investigated the potential for this approach by determining whether bisphosphonates interact with osteoblasts in vitro. The effects of pamidronate (P), clodronate (C), and etidronate (E) in solution and when coated onto HA were investigated. P inhibited protein and collagen syntheses potently when in solution, but not after being bound to HA. When bound to HA, both P and C increased DNA, protein and collagen syntheses of osteoblasts and may encourage the osseointegration of implants. The pharmacological effects of the bisphosphonates studied altered dramatically after binding to HA. This must be fully investigated before this approach to prolonging prostheses stability can be evaluated.",
    keywords = "materials science, bioengineering, bisphosphonates, osteoblasts",
    author = "A. Ganguli and C. Henderson and M.H. Grant and S.T. Meikle and A.W. Lloyd and I. Goldie",
    year = "2002",
    doi = "10.1023/A:1019892109411",
    language = "English",
    volume = "13",
    pages = "923--931",
    journal = "Journal of Materials Science: Materials in Medicine",
    issn = "0957-4530",
    number = "10",

    }

    The interactions of bisphosphonates in solution and as coatings on hydroxyapatite with osteoblasts. / Ganguli, A.; Henderson, C.; Grant, M.H.; Meikle, S.T.; Lloyd, A.W.; Goldie, I.

    In: Journal of Materials Science: Materials in Medicine, Vol. 13, No. 10, 2002, p. 923-931.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - The interactions of bisphosphonates in solution and as coatings on hydroxyapatite with osteoblasts

    AU - Ganguli, A.

    AU - Henderson, C.

    AU - Grant, M.H.

    AU - Meikle, S.T.

    AU - Lloyd, A.W.

    AU - Goldie, I.

    PY - 2002

    Y1 - 2002

    N2 - Aseptic loosening is one of the major causes of failure of artificial hip joints, and it can occur for several reasons, including osteolysis of the bone tissue in response to stress shielding or cellular reactions to wear debris. Any treatment of the prosthesis which could minimize the osteolytic response of bone tissue may be able to extend the life-time of the implant. Bisphosphonates are potent inhibitors of osteoclastic bone resorption, and they bind avidly to hydroxyapatite (HA). Coating the prostheses with bisphosphonates may therefore inhibit osteolysis. We have investigated the potential for this approach by determining whether bisphosphonates interact with osteoblasts in vitro. The effects of pamidronate (P), clodronate (C), and etidronate (E) in solution and when coated onto HA were investigated. P inhibited protein and collagen syntheses potently when in solution, but not after being bound to HA. When bound to HA, both P and C increased DNA, protein and collagen syntheses of osteoblasts and may encourage the osseointegration of implants. The pharmacological effects of the bisphosphonates studied altered dramatically after binding to HA. This must be fully investigated before this approach to prolonging prostheses stability can be evaluated.

    AB - Aseptic loosening is one of the major causes of failure of artificial hip joints, and it can occur for several reasons, including osteolysis of the bone tissue in response to stress shielding or cellular reactions to wear debris. Any treatment of the prosthesis which could minimize the osteolytic response of bone tissue may be able to extend the life-time of the implant. Bisphosphonates are potent inhibitors of osteoclastic bone resorption, and they bind avidly to hydroxyapatite (HA). Coating the prostheses with bisphosphonates may therefore inhibit osteolysis. We have investigated the potential for this approach by determining whether bisphosphonates interact with osteoblasts in vitro. The effects of pamidronate (P), clodronate (C), and etidronate (E) in solution and when coated onto HA were investigated. P inhibited protein and collagen syntheses potently when in solution, but not after being bound to HA. When bound to HA, both P and C increased DNA, protein and collagen syntheses of osteoblasts and may encourage the osseointegration of implants. The pharmacological effects of the bisphosphonates studied altered dramatically after binding to HA. This must be fully investigated before this approach to prolonging prostheses stability can be evaluated.

    KW - materials science

    KW - bioengineering

    KW - bisphosphonates

    KW - osteoblasts

    UR - http://dx.doi.org/10.1023/A:1019892109411

    U2 - 10.1023/A:1019892109411

    DO - 10.1023/A:1019892109411

    M3 - Article

    VL - 13

    SP - 923

    EP - 931

    JO - Journal of Materials Science: Materials in Medicine

    JF - Journal of Materials Science: Materials in Medicine

    SN - 0957-4530

    IS - 10

    ER -